15 reports of this reaction
4.0% of all OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE reports
#1 most reported adverse reaction
DIARRHOEA is the #1 most commonly reported adverse reaction for OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE, manufactured by Accord Healthcare Inc.. There are 15 FDA adverse event reports linking OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE to DIARRHOEA. This represents approximately 4.0% of all 373 adverse event reports for this drug.
Patients taking OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE who experience diarrhoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DIARRHOEA is moderately reported among OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE users, representing a notable but not dominant share of adverse events.
In addition to diarrhoea, the following adverse reactions have been reported for OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE:
The following drugs have also been linked to diarrhoea in FDA adverse event reports:
DIARRHOEA has been reported as an adverse event in 15 FDA reports for OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DIARRHOEA accounts for approximately 4.0% of all adverse event reports for OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE, making it one of the most commonly reported side effect.
If you experience diarrhoea while taking OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.